Brief: BioArctic Says Sales Of Leqembi Totaled 1.1 Billion Yen In Q4 2023
Feb 5 (Reuters) - BioArctic AB BIOAb.ST :
* SALES OF LEQEMBI® TOTALED 1.1 BILLION YEN IN Q4 2023
* IN TOTAL, SALES OF JPY 1.1 BILLION WERE RECORDED IN Q4,
RESULTING IN A ROYALTY TO BIOARCTIC AMOUNTING TO SEK 7.3 MILLION
Source text for Eikon: ID:nWkr2tGb85
Further company coverage: BIOAb.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million